SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001485003-17-000048
Filing Date
2017-05-04
Accepted
2017-05-04 16:56:21
Documents
46
Period of Report
2017-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q ebio-033117x10q.htm 10-Q 499503
2 EXHIBIT 31.1 ebio-033117x311.htm EX-31.1 12080
3 EXHIBIT 31.2 ebio-033117x312.htm EX-31.2 11946
4 EXHIBIT 32.1 ebio-033117x321.htm EX-32.1 7008
  Complete submission text file 0001485003-17-000048.txt   2716045

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT ebio-20170331.xml EX-101.INS 481998
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ebio-20170331.xsd EX-101.SCH 21385
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT ebio-20170331_cal.xml EX-101.CAL 47897
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT ebio-20170331_def.xml EX-101.DEF 84893
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT ebio-20170331_lab.xml EX-101.LAB 327616
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ebio-20170331_pre.xml EX-101.PRE 191140
Mailing Address 245 FIRST STREET SUITE 1800 CAMBRIDGE MA 02142
Business Address 245 FIRST STREET SUITE 1800 CAMBRIDGE MA 02142 617-444-8550
Eleven Biotherapeutics, Inc. (Filer) CIK: 0001485003 (see all company filings)

IRS No.: 262025616 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36296 | Film No.: 17814881
SIC: 2834 Pharmaceutical Preparations